Cancer Immunotherapy Trials Underutilize Immune Response Monitoring

Immune‐related radiological and biomarker monitoring in cancer immunotherapy trials permits interrogation of efficacy and reasons for therapeutic failure. We report the results from a cross‐sectional analysis of response monitoring in 685 T‐cell checkpoint‐targeted cancer immunotherapy trials in sol...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Oncologist
Main Authors: Connell, Claire M., Raby, Sophie E.M., Beh, Ian, Flint, Thomas R., Williams, Edward H., Fearon, Douglas T., Jodrell, Duncan I., Janowitz, Tobias
Formato: Artigo
Idioma:Inglês
Publicado em: AlphaMed Press 2017
Assuntos:
Brief Communications
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5759814/
https://ncbi.nlm.nih.gov/pubmed/29021379
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1634/theoncologist.2017-0226
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados